

Wall Street analysts raised targets for MSTR, FOXA, NRIX, ZETA and TWLO, while cutting targets for CAMT and DVN.
You can purchase shares of Nurix Therapeutics (NASDAQ:NRIX) through any online brokerage.
Other companies in Nurix Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Nurix Therapeutics has a consensus price target of $32.57.
The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $25.81 last updated November 2, 2026 at 10:36 AM EST.
There are no upcoming dividends for Nurix Therapeutics.
Nurix Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Nurix Therapeutics.
Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated...